Published in Ann Intern Med on March 16, 2010
A prospective study of the use and effects of screening mammography in women aged 70 and older. J Am Geriatr Soc (2014) 2.65
Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications. BJU Int (2013) 2.10
Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc (2013) 2.08
Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med (2011) 1.64
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci (2013) 1.57
Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause (2011) 1.55
Gender and race/ethnicity differences in hip fracture incidence, morbidity, mortality, and function. Clin Orthop Relat Res (2011) 1.49
Fee-based care is important for access to prompt treatment of hip fractures among veterans. Clin Orthop Relat Res (2013) 1.47
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res (2013) 1.44
Let's talk about sex, baby: gendered innovations in orthopaedic science. Clin Orthop Relat Res (2014) 1.29
Sex steroid actions in male bone. Endocr Rev (2014) 1.26
The 1-year mortality of patients treated in a hip fracture program for elders. Geriatr Orthop Surg Rehabil (2010) 1.16
Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporos Int (2012) 1.14
Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study. Clin Interv Aging (2013) 1.14
Excess mortality after hip fracture among elderly women in Norway. The HUNT study. Osteoporos Int (2011) 1.10
Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA. Osteoporos Int (2016) 1.09
Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int (2012) 1.08
Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly. Int Orthop (2010) 1.08
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. Diabetologia (2012) 1.08
The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res (2014) 1.08
Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci (2013) 1.03
Randomized trial of hemiarthroplasty versus internal fixation for femoral neck fractures: no differences at 6 years. Clin Orthop Relat Res (2013) 1.02
All-cause and cause-specific mortality after hip fracture among Chinese women and men: the Singapore Chinese Health Study. Osteoporos Int (2012) 1.02
The Elders Risk Assessment Index, an electronic administrative database-derived frailty index, can identify risk of hip fracture in a cohort of community-dwelling adults. Mayo Clin Proc (2012) 1.00
Gender differences in osteoporosis and fractures. Clin Orthop Relat Res (2011) 1.00
Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS (2014) 1.00
The epidemic of hip fractures: are we on the right track? PLoS One (2011) 0.99
Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland. J Bone Miner Res (2014) 0.99
Surgery for hip fracture yields societal benefits that exceed the direct medical costs. Clin Orthop Relat Res (2014) 0.96
Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study. Int Orthop (2014) 0.95
Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study. Osteoporos Int (2011) 0.95
Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res (2014) 0.95
Prevention and clinical management of hip fractures in patients with dementia. Geriatr Orthop Surg Rehabil (2010) 0.94
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures. Osteoporos Int (2013) 0.94
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Osteoporos Int (2012) 0.92
Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int (2013) 0.92
A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer. PLoS One (2013) 0.92
Postoperative admission to a dedicated geriatric unit decreases mortality in elderly patients with hip fracture. PLoS One (2014) 0.92
Maximising functional recovery following hip fracture in frail seniors. Best Pract Res Clin Rheumatol (2013) 0.90
The development of a comprehensive multidisciplinary care pathway for patients with a hip fracture: design and results of a clinical trial. BMC Musculoskelet Disord (2014) 0.90
Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States. Pharmacoepidemiol Drug Saf (2011) 0.90
Delay from fracture to hospital admission: a new risk factor for hip fracture mortality? Osteoporos Int (2012) 0.89
Fracture risk in nursing home residents initiating antipsychotic medications. J Am Geriatr Soc (2013) 0.89
Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab (2014) 0.88
Early interdisciplinary hospital intervention for elderly patients with hip fractures : functional outcome and mortality. Clinics (Sao Paulo) (2012) 0.88
Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil (2010) 0.87
Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision. Osteoporos Int (2015) 0.87
The impact of care pathways for patients with proximal femur fracture: rationale and design of a cluster-randomized controlled trial. BMC Health Serv Res (2012) 0.86
The economics of improving medication adherence in osteoporosis: validation and application of a simulation model. J Clin Endocrinol Metab (2011) 0.86
Impact of heart failure on hip fracture outcomes: a population-based study. J Hosp Med (2011) 0.86
Effect of Teriparatide on Bone Formation in the Human Femoral Neck. J Clin Endocrinol Metab (2016) 0.86
Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop (2015) 0.85
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS). Calcif Tissue Int (2012) 0.85
Osteoporosis medication adherence: physician perceptions vs. patients' utilization. Bone (2013) 0.85
Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions. Osteoporos Int (2011) 0.85
Osteoporosis in men. Nat Rev Endocrinol (2013) 0.85
Which patients are at risk for kidney dysfunction after hip fracture surgery? Clin Orthop Relat Res (2013) 0.85
Predictors of short- and long-term mortality in males and females with hip fracture - a prospective observational cohort study. PLoS One (2013) 0.85
Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study. Medicine (Baltimore) (2015) 0.85
Physical activity and hip fracture disability: a review. J Aging Res (2011) 0.84
Exercise prescription after fragility fracture in older adults: a scoping review. Osteoporos Int (2010) 0.84
Value of routine blood tests for prediction of mortality risk in hip fracture patients. Acta Orthop (2012) 0.84
Mortality following hip fracture in men with prostate cancer. PLoS One (2013) 0.84
Surgical treatment of hip fractures: factors influencing mortality. Hippokratia (2013) 0.84
Osteoporosis: the emperor has no clothes. J Intern Med (2015) 0.84
The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm. PLoS One (2015) 0.83
Effect of time factors on the mortality in brittle hip fracture. J Orthop Surg Res (2014) 0.83
Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int (2014) 0.83
Reducing mortality in hip fracture patients using a perioperative approach and "Patient- Centered Medical Home" model: a prospective cohort study. Patient Saf Surg (2014) 0.82
Effect of a multifactorial fall-and-fracture risk assessment and management program on gait and balance performances and disability in hospitalized older adults: a controlled study. Osteoporos Int (2012) 0.82
The incidence of hip fractures in Estonia, 2005-2012. Osteoporos Int (2014) 0.82
Age-related changes in the fracture resistance of male Fischer F344 rat bone. Bone (2015) 0.81
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Arch Public Health (2015) 0.81
Clinical presentation and outcome of perioperative myocardial infarction in the very elderly following hip fracture surgery. J Hosp Med (2012) 0.81
Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studies. BMC Geriatr (2014) 0.81
Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease. Rheumatol Int (2013) 0.81
Non-spinal musculoskeletal malpractice suits against radiologists in the USA--rates, anatomic locations, and payments in a survey of 8,265 radiologists. Emerg Radiol (2013) 0.81
Excess mortality associated with second hip fracture. Osteoporos Int (2015) 0.81
Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev (2017) 0.81
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporos Int (2015) 0.81
DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR). J Frailty Aging (2014) 0.80
Mortality and complications after hip fracture among elderly patients undergoing hemodialysis. BMC Nephrol (2015) 0.80
The effect of care pathways for hip fractures: a systematic overview of secondary studies. Eur J Orthop Surg Traumatol (2012) 0.80
Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study. Eur J Clin Pharmacol (2012) 0.80
Alcohol consumption and hip fracture risk. Osteoporos Int (2014) 0.80
Fracture incidence in a large cohort of men age 30 years and older with osteoporosis. Osteoporos Int (2015) 0.80
Physical activity and inactivity and risk of hip fractures in men. Am J Public Health (2014) 0.80
Prediction of mortality in hip fracture patients: role of routine blood tests. Arch Bone Jt Surg (2015) 0.80
Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand. BMC Cancer (2015) 0.79
Cost and management of males with closed fractures. Osteoporos Int (2012) 0.79
Preference for wine is associated with lower hip fracture incidence in post-menopausal women. BMC Womens Health (2013) 0.79
Clinical utility of denosumab for treatment of bone loss in men and women. Clin Interv Aging (2011) 0.79
Serum free estradiol and estrogen receptor-α mediated activity are related to decreased incident hip fractures in older women. Bone (2012) 0.79
Hypovitaminosis D and Other Risk Factors of Femoral Neck Fracture in South Indian Postmenopausal Women: A Pilot Study. J Clin Diagn Res (2015) 0.79
Clinical impact of recent genetic discoveries in osteoporosis. Appl Clin Genet (2013) 0.79
The link between nutritional parameters and bone mineral density in women: results of a screening programme for osteoporosis. J Transl Med (2014) 0.79
Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture. Osteoporos Int (2014) 0.79
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc (2004) 5.80
Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA (2009) 5.60
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci (2000) 4.19
Risk of mortality following clinical fractures. Osteoporos Int (2000) 3.76
Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2007) 3.16
Multivariable analysis: a primer for readers of medical research. Ann Intern Med (2003) 3.14
The crippling consequences of fractures and their impact on quality of life. Am J Med (1997) 2.98
Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health (1997) 2.68
Race and sex differences in mortality following fracture of the hip. Am J Public Health (1992) 2.63
Survival experience of aged hip fracture patients. Am J Public Health (1989) 2.46
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
Factors associated with mortality after hip fracture. Osteoporos Int (2000) 2.35
Hip fracture incidence and mortality in New England. Epidemiology (1991) 2.32
Survival and ambulation following hip fracture. J Bone Joint Surg Am (1978) 2.31
Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int (1999) 2.28
Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev (2002) 2.23
Mortality risk after hip fracture. J Orthop Trauma (2003) 2.12
Mortality after hip fractures. Acta Orthop Scand (1979) 2.05
Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med (1996) 2.05
Mortality and life expectancy after hip fractures. Acta Orthop Scand (1980) 1.97
Survival after hip fracture. Osteoporos Int (2005) 1.93
Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int (2003) 1.91
Toward an understanding of frailty. Ann Intern Med (1999) 1.87
Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int (2007) 1.86
Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health (1994) 1.83
Residual lifetime risk of fractures in women and men. J Bone Miner Res (2007) 1.82
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76
Gender differences in mortality after hip fracture: the role of infection. J Bone Miner Res (2003) 1.73
Morbidity and mortality following fractures of the femoral neck and trochanteric region: analysis of risk factors. J Trauma (1989) 1.72
Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res (1995) 1.69
Mortality and institutionalization following hip fracture. J Am Geriatr Soc (2000) 1.65
[Replacement of the femoral head due to fracture of the hip: prognostic factors for the duration of hospitalisation, institutionalisation and mortality]. Ned Tijdschr Geneeskd (2003) 1.51
Quality of life, morbidity, and mortality after low trauma hip fracture in men. Ann Rheum Dis (2005) 1.48
The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group. J Bone Joint Surg Am (2001) 1.48
Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int (2002) 1.47
Health status before and mortality after hip fracture. Am J Public Health (1996) 1.46
Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study. J Am Geriatr Soc (2004) 1.45
Time trends of mortality after first hip fractures. Osteoporos Int (2007) 1.40
Adjusted mortality after hip fracture: From the cardiovascular health study. J Am Geriatr Soc (2006) 1.38
Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab (2006) 1.37
Mortality and mobility after hip fracture in Japan: a ten-year follow-up. J Bone Joint Surg Br (2007) 1.36
Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int (2000) 1.35
Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5-18.5 years. J Orthop Trauma (1993) 1.32
Factors affecting postoperative mortality of patients with displaced femoral neck fracture. Injury (2006) 1.25
Mortality after cervical hip fracture. 3002 patients followed for 6 years. Acta Orthop Scand (1986) 1.22
Persistent changes in interleukin-6 and lower extremity function following hip fracture. J Gerontol A Biol Sci Med Sci (2006) 1.19
Gender differences in functioning after hip fracture. J Gerontol A Biol Sci Med Sci (2006) 1.19
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int (2001) 1.18
Intervention thresholds for osteoporosis in the UK. Bone (2004) 1.18
The mortality and social prognosis of hip fractures. A prospective multifactorial study. Int Orthop (1994) 1.17
Ten-year survival after fractures of the proximal end of the femur. Gerontology (1988) 1.14
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int (2004) 1.09
Predictors of first hip fracture and mortality post fracture in older women. Ir J Med Sci (2001) 1.09
Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol (2007) 1.06
Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Hum Reprod (1997) 1.03
Survival after trochanteric fracture. Biological factors analyzed in 270 patients. Acta Orthop Scand (1992) 1.01
Predictors of hip fractures in elderly men. J Bone Miner Res (1995) 1.01
Years of potential life lost after hip fracture among postmenopausal women. Acta Orthop Scand (1992) 0.96
Age-related hip fractures in men: clinical spectrum and short-term outcomes. Osteoporos Int (1995) 0.92
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials. Stat Med (2002) 0.88
Mortality and quality of life after trochanteric hip fracture. Public Health (2001) 0.85
Consequences of hip fracture among Thai women aged 50 years and over: a prospective study. J Med Assoc Thai (2000) 0.81
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med (2007) 7.60
Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med (2011) 7.52
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66
Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med (2014) 6.56
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47
Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med (2010) 6.13
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab (2008) 3.67
Concern Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA (2007) 3.63
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Association of timing of surgery for hip fracture and patient outcomes. JAMA (2004) 3.51
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Interventions for preventing falls in acute- and chronic-care hospitals: a systematic review and meta-analysis. J Am Geriatr Soc (2007) 3.14
Medication undertreatment in assisted living settings. Arch Intern Med (2004) 3.00
Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci (2003) 2.78
The impact of post-operative pain on outcomes following hip fracture. Pain (2003) 2.66
The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med (2007) 2.66
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis. J Bone Miner Res (2011) 2.53
Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J Bone Miner Res (2003) 2.47
Association of hypogonadism with vitamin D status: the European Male Ageing Study. Eur J Endocrinol (2011) 2.28
Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care (2002) 2.20
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol (2014) 2.13
Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab (2007) 2.11
The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer. J Geriatr Oncol (2013) 2.07
The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab (2008) 2.06
Androgens and bone. Endocr Rev (2004) 2.06
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res (2008) 2.04
Assisted living and nursing homes: apples and oranges? Gerontologist (2003) 2.03
Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Environ Health Perspect (2002) 2.03
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab (2010) 2.01
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 1.98
The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int (2003) 1.97
Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol (2008) 1.96
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. Bone (2007) 1.94
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92
Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int (2003) 1.91
Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion (2006) 1.91
Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res (2009) 1.89
Prediction of fracture in nursing home residents. J Am Geriatr Soc (2002) 1.86
Treatment fidelity in behavior change research: a case example. Nurs Res (2005) 1.84
Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc (2003) 1.84
Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care (2003) 1.82
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.78
Hospital readmissions after hospital discharge for hip fracture: surgical and nonsurgical causes and effect on outcomes. J Am Geriatr Soc (2003) 1.78
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis. J Bone Miner Res (2012) 1.78
Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res (2008) 1.78
Black/White differences in pressure ulcer incidence in nursing home residents. J Am Geriatr Soc (2004) 1.76
Recruitment and retention of older adults in aging research. J Am Geriatr Soc (2008) 1.73
Gender differences in mortality after hip fracture: the role of infection. J Bone Miner Res (2003) 1.73
The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther (2005) 1.72
Nursing home facility risk factors for infection and hospitalization: importance of registered nurse turnover, administration, and social factors. J Am Geriatr Soc (2002) 1.72
Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology (2009) 1.66
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol (2012) 1.65
How good is assisted living? Findings and implications from an outcomes study. J Gerontol B Psychol Sci Soc Sci (2005) 1.63
The association of race, gender, and comorbidity with mortality and function after hip fracture. J Gerontol A Biol Sci Med Sci (2008) 1.63
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc (2010) 1.62
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res (2014) 1.62
Medication adherence in patients with chronic non-malignant pain: is there a problem? Eur J Pain (2008) 1.62
Patient relocation in the 6 months after hip fracture: risk factors for fragmented care. J Am Geriatr Soc (2004) 1.60
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). J Sex Med (2013) 1.59
Frailty and sexual health in older European men. J Gerontol A Biol Sci Med Sci (2012) 1.58
Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc (2011) 1.57
Hip fracture in the older patient: reasons for delay in hospitalization and timing of surgical repair. J Am Geriatr Soc (2002) 1.56
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg Am (2012) 1.54
Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc (2003) 1.53
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab (2008) 1.53
The relationships between sex hormones and sexual function in middle-aged and older European men. J Clin Endocrinol Metab (2011) 1.53
Patients with hip fracture: subgroups and their outcomes. J Am Geriatr Soc (2002) 1.52
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
Tasks performance by registered nurses and care assistants in nursing homes: a quantitative comparison of survey data. Int J Nurs Stud (2007) 1.51
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Characteristics and effectiveness of fall prevention programs in nursing homes: a systematic review and meta-analysis of randomized controlled trials. J Am Geriatr Soc (2015) 1.49
Pressure ulcers and the transition to long-term care. Adv Skin Wound Care (2003) 1.49
Certified nursing assistants' explanatory models of nursing home resident depression. West J Nurs Res (2008) 1.46
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry (2009) 1.44
Sequential therapy in the treatment of osteoporosis. Curr Med Res Opin (2011) 1.44
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res (2013) 1.44
Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res (2005) 1.42
Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome. Fertil Steril (2011) 1.42
The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma (2004) 1.41
Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men. Pain (2011) 1.41
Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab (2013) 1.40